2nd Medical Communication Workshop

概要

Advanced registraion has been closed.

Please come to the on-site Registration Desk if you would like to attend.

This symposium will be conducted in Japanese Language.

Want to learn more about 2nd Medical Communication Workshop? You've come to the right site!

Keiko Tsumori, MSC Associate Principle Scientist, Medical Writing, Regulatory Affairs Area, Japan D
MSD K.K., Japan
Yuko Kojima, RPH Sr. Executive Director
Eli Lilly Japan K.K., Japan
Rika Abe, RPH Research Administrator, Office of the Fugaku Society 5.0 Initiative
RIKEN Center for Computational Science, Japan
Yasufumi Kuroda, PHD Senior Director
Daiichi Sankyo Company, Limited, Japan
Hiroki Nagahama, MS Director, Japan Safety Risk Management Lead, Clinical Safety & Pharmacovigilance
GlaxoSmithKline K.K., Japan
Shohko Sekine Reviewer, Office of New Drug IV
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Naoko Tejima Group Manager, Regulatory Writing & Operations Group, Regulatory Affairs
Astellas Amgen Biopharma, Japan
Seiki Yamazaki Director, Clinical Informatics & Innovation
Pfizer Japan Inc., Japan
Hideo Nakada, RPH Deputy Associate Manager, Department of Hospital Pharmacy
Keio University, Japan

Download